Psoriasis/Psoriatic Arthritis Patients’ Long-term Treatment Patterns and Adherence to Systemic Treatments Monitoring Recommendations
Acta Dermato-Venereologica · 15.06.2023 · 103 · adv6505
DOI: 10.2340/actadv.v103.6505 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Dermato-Venereologica, online erschienen am 15.06.2023. Verfasst von Åsa Krantz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology and Venereology Section, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Arthritis, Psoriatic, Biological Products, Psoriasis. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Limited information exists regarding treatment of patients with psoriasis/psoriatic arthritis in primary care. The aim of this study is to assess treatment patterns, adherence, persistence, and compliance in newly diagnosed patients with psoriasis/psoriatic arthritis from 2012 to 2018 in Stockholm, Sweden. In addition, laboratory monitoring before initiation of treatment and at recommended intervals was quantified for patients prescribed methotrexate or biologics. A total of 51,639 individuals were included, with 39% initiating treatment with topical corticosteroids and < 5% receiving systemic treatment within 6 months post-diagnosis. During a median (interquartile range) follow-up of 7 (4–8) years, 18% of patients received systemic treatments at some point. Overall, 5-year persistence rates were 32%, 45% and 19% for methotrexate, biologics, and other systemic treatments, respectively. Pre-initiation laboratory tests, as recommended by guidelines, were performed in approximately 70% and 62% of methotrexate and biologics users, respectively. Follow-up monitoring at recommended time intervals occurred in 14–20% and 31–33% of patients prescribed methotrexate and biologics, respectively. These findings highlight gaps in the pharmacological care of patients with psoriasis/psoriatic arthritis, including suboptimal adherence/persistence and inadequate laboratory monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Dermatology and Venereology Section, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Sweden.
- Amgen Sweden. lschalin@amgen.com.
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Sweden. faizan.mazhar@ki.se.
Zitieren
APA
Krantz, Å., Carrero, J. J., Yang, Y., Schalin, L., Lysell, J., & Mazhar, F. (2023). Psoriasis/Psoriatic Arthritis Patients’ Long-term Treatment Patterns and Adherence to Systemic Treatments Monitoring Recommendations. Acta Dermato-Venereologica, 103, adv6505. https://doi.org/10.2340/actadv.v103.6505
Vancouver
Krantz Å, Carrero JJ, Yang Y, Schalin L, Lysell J, Mazhar F. Psoriasis/Psoriatic Arthritis Patients’ Long-term Treatment Patterns and Adherence to Systemic Treatments Monitoring Recommendations. Acta Dermato-Venereologica. 2023;103:adv6505. doi:10.2340/actadv.v103.6505
BibTeX
@article{Krantz2023,
author = {Krantz, Åsa and Carrero, Juan Jesus and Yang, Yuanhang and Schalin, Lovisa and Lysell, Josefin and Mazhar, Faizan},
title = {Psoriasis/Psoriatic Arthritis Patients’ Long-term Treatment Patterns and Adherence to Systemic Treatments Monitoring Recommendations},
journal = {Acta Dermato-Venereologica},
year = {2023},
volume = {103},
pages = {adv6505},
doi = {10.2340/actadv.v103.6505}
}
EUVIMED